Has Toshimasa Okabe, MD received payments from drug or device companies?

Yes. Drug and device makers reported $113,816 in general payments to Toshimasa Okabe, MD across 278 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Toshimasa Okabe, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Toshimasa Okabe, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Toshimasa Okabe, MD

Clinical Cardiac Electrophysiology · Seattle, WANPI 1972767762

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 81.6% of it on its own, with 6 other manufacturers making up the rest. Among clinical cardiac electrophysiology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$113,816in general payments, 2019–2025

Across 278 payments — averaging $409.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$93K
Medtronic$7K
Medical Device Business Services, Inc.$5K
Boston Scientific$5K
Atricure, Inc.$3K
Biosense Webster, Inc.$713
plus $97 from 1 others

$232,845in research payments, 2019–2025

Across 206 payments — averaging $1130.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$87K
Medtronic$50K
Impulse Dynamics (USA) Inc.$35K
Biotronik Inc.$34K
Boston Scientific$27K

What the payments were for

Consulting fees$54,44148%
Speaking & faculty fees$29,99526%
Travel & lodging$19,78817%
Food & beverage$9,5918%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	184	$92,892
Medtronic(2 entities)	29	$6,692
Medical Device Business Services, Inc.	7	$5,201
Boston Scientific	43	$4,888
Atricure, Inc.	3	$3,333
Biosense Webster, Inc.	11	$713
Cardiva Medical, Inc.	1	$97

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ENSITE PRECISION$29,295
TACTICATH ABLATION CATHETER, SENSOR ENABLED$13,402
Perclose ProGlide suture mediated closure system$10,621
Ensite Cardiac Mapping System$7,914
ADVISOR$6,130
Omnilink Elite vascular stent system$4,925
ENSITE$4,912
Carto 3 System$4,500
EnSite Precision Cardiac Mapping System$4,400
AVEIR$2,418
GENERAL - THERAPIES$2,087
Advisor Catheter$1,800
SelectSecure$815
Carto 3$807
Tendril Pacing Lead$800
Accent Pacemaker$800
Reveal LINQ$594
RESONATE EL ICD VR$582
Micra$494
Farapulse$317

How this compares

$113,816 in reported general payments places this provider in the 95th percentile of 68 clinical cardiac electrophysiology providers in Washington.

See all clinical cardiac electrophysiology providers in Washington →

Medicare billing

Part B allowed, 2024

$140,144

Medicare patients

286

Services billed

883

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	57	$68,015
XareltoRivaroxaban	15	$24,315
SotalolSotalol Hcl	30	$539
Flecainide Acetate	15	$475
Diltiazem 24hr Er (Cd)Diltiazem Hcl	19	$466
Metoprolol Succinate	44	$453
Amiodarone Hcl	24	$447
Atenolol	12	$61

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Seattle

Gust BardySeattle$130.7M
Babak NazerSeattle$124K
Darryl WellsSeattle$112K
Arun R Mahankali SridharSeattle$94K
Jeanne PooleSeattle$81K
David RosenthalSeattle$54K
Eathar RazakSeattle$50K
Uyanga BatnyamSeattle$38K
Carlos AlvesSeattle$29K
Robert RhoSeattle$29K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →